跳至主要内容
临床试验/NCT04028531
NCT04028531招募中不适用

Understanding Chronic Lymphocytic Leukemia

Dana-Farber Cancer Institute2 个研究点 分布在 1 个国家目标入组 2,750 人开始时间: 1999年9月29日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
2,750
试验地点
2
主要终点
Incidence of novel genomic prognostic markers in Chronic Lymphocytic Leukemia

研究概览

简要总结

The purpose of this study is to collect human Chronic Lymphocytic Leukemia tissue samples and medical information, in order to find out more about the causes and biology of chronic lymphocytic leukemia.

详细描述

The purpose of this study is to collect human Chronic Lymphocytic Leukemia tissue samples and medical information, in order to find out more about the causes and biology of chronic lymphocytic leukemia, for the potential development of more effective therapies for this disease.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Other

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • New and existing patients seen for treatment of monoclonal B-cell lymphocytosis
  • Any low grade lymphoproliferative disorder
  • Chronic Lymphocytic Leukemia in the Dana Farber Cancer Institute Hematologic Oncology Clinic or elsewhere

排除标准

  • 未提供

研究组 & 干预措施

Sample Collection

  • Blood tests required for assessment
  • Specimens and data will also be collected from outside sites
  • Clinical data from patients with Chronic Lymphocytic Leukemia will be gathered into a database at Dana Farber Cancer Institute

结局指标

主要结局

Incidence of novel genomic prognostic markers in Chronic Lymphocytic Leukemia

时间窗: 20 years

Exploratory science to better understand Chronic Lymphocytic Leukemia

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jennifer R. Brown, MD, PhD

Principal Investigator

Dana-Farber Cancer Institute

研究点 (2)

Loading locations...

相似试验